Population Pharmacokinetics of Nevirapine, Zidovudine, and Didanosine in Human Immunodeficiency Virus-Infected Patients

The population pharmacokinetics of nevirapine (NVP), zidovudine (ZDV), and didanosine (ddI) were evaluated in a total of 175 patients infected with human immunodeficiency virus randomized to receive either a double combination of ZDV plus ddI or a triple combination of NVP plus ZDV plus ddI as a sub...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	Antimicrob Agents Chemother
Asıl Yazarlar:	Zhou, Xiao-Jian, Sheiner, Lewis B., D’Aquila, Richard T., Hughes, Michael D., Hirsch, Martin S., Fischl, Margaret A., Johnson, Victoria A., Myers, Maureen, Sommadossi, Jean-Pierre
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1999
Konular:	Antiviral Agents
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89031/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9869576/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.1.121
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Population Pharmacokinetics of Nevirapine, Zidovudine, and Didanosine in Human Immunodeficiency Virus-Infected Patients

Benzer Materyaller